在接受同时化学或放射治疗的宫癌患者中,MORC2表达与无进展生存的关联

Jing He1,2, Xiao-Hong Liao2, Bing-Di Zhong2

  • 1Department of Oncology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China.

Medicine
|September 23, 2024
PubMed
概括

高MORC2蛋白表达表明接受化疗放射治疗的宫癌患者的生存结果不佳. 这一发现表明MORC2是局部晚期宫癌的潜在预后生物标志物.